US NIH halts clinical trial of hydroxychloroquine
A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with COVID-19 has been stopped by the U.S. National Institutes of Health (NIH), the agency announced on Saturday.








